Convergence of Point-of-Care testing and Digital Health Creates Growth Opportunities for Companies to Monetize

Focus increases on data and remote monitoring capabilities, explains GIL Briefing by Frost & Sullivan's Transformational Health Team

LONDON, Aug. 31, 2016 /PRNewswire/ --

WHEN	Wednesday, 7 th September, 2016 at 5:00 pm BST
LOCATION:	Online, with Complimentary Registration, please contact [e-mail]
SPEAKERS:	Divyaa Ravishankar, Frost & Sullivan Senior Industry Analyst and guest speakers Paul Pickering, President and CEO, Ubiquitome and Herbert Torfs, VP Business Development and Strategy, GenePOC

The cost of care is constantly increasing across segments. As a result, healthcare delivery is moving toward decentralization. Delivery from health settings such as mobile clinics, rapid retail clinics and home settings demand the use of point-of-care diagnostics. Effective delivery of healthcare has created convergence in both business and technology between point-of-care testing and digital health. An increased focus is placed on data and remote monitoring capabilities.

Photo - http://photos.prnewswire.com/prnh/20160831/402966

"Taking cognizance of the changing market segmentation and emerging opportunities will prove crucial for device manufacturers and other stakeholders in the value chain," finds Divyaa Ravishankar, Frost & Sullivan Senior Industry Analyst. "Otherwise they risk missing the decisive innovations and will lag behind in the experience curve." In a highly dynamic market as this, market participants need to make use of the right time and technology to capitalize on the trend to move ahead.

This GIL Briefing will help identify:

• Early stage companies that are moving toward simplicity of testing
• Areas of point-of-care testing which category leaders consider for future growth and expansion
• The key convergences which will drive sector growth
• How the segment will evolve or change
• Trends and pricing strategies in Europe and other developing countries like India and China

Community pharmacies and low volume physician office laboratories are excellent customers that offer medical diagnostic testing near the point of care. Given the initial hesitancy sensed in the case of physician prescribing POCs, suppliers can offer the rental equipment model and seek partnerships with community pharmacies for new and upcoming tests to create awareness with patient through walk-in testing or workplace testing. Companies who succeed in the POCT market are those that adopt strategies to increase the usability of tests. Exploring new customer groups and understanding their needs will disrupt their way of doing business.